北美良性前列腺增生设备市场预测至 2028 年 – COVID-19 影响和区域分析 – 按产品（电切镜、泌尿科激光、射频消融设备、前列腺支架和植入物）、手术类型（经尿道微波治疗、经尿道前列腺切除术、经尿道前列腺针消融术、激光手术、尿提升手术等）和最终用户（医院、诊所、门诊手术中心等）
No. of Pages: 146 | Report Code: BMIRE00027169 | Category: Life Sciences
No. of Pages: 146 | Report Code: BMIRE00027169 | Category: Life Sciences
良性前列腺增生 (BPH) 是由细胞过度生长引起的前列腺肿大在前列腺中。这种非癌性前列腺疾病通常不会致命。由于是良性的，这种情况不涉及身体其他部位的转移。 BPH 与前列腺癌的风险无关；此外，除非出现症状，否则前列腺增生症不被视为健康问题。几乎所有男性到 70 岁时，前列腺都可能出现一定程度的生长。衰老、腹部肥胖和体育锻炼不足会增加患 BPH 的风险。根据国家生物技术信息中心 (NCBI) 的数据，前列腺肥大是老年男性最常见的疾病之一，也是下尿路症状 (LUTS) 的主要原因。 40岁以后，BPH的患病率上升，到90岁时达到峰值60%。许多尸检研究表明，BPH的组织学患病率在第四、六、六岁分别为8%、50%、80%。分别是一个人生命的九个十年。在美国进行的观察性研究表明，老年也是临床 BPH 发病和进展的危险因素。根据克林彭和巴尔的摩老龄化纵向研究的统计，老年男性的前列腺以每年 2.0-2.5% 的速度增长。持续的前列腺肿大可能发展为 LUTS，较大的前列腺与良性前列腺肿大 (BPE) 相关，这会引发临床 BPH 和尿失禁的风险。根据 NCBI 数据，发现肥胖增加与前列腺体积呈正相关。在许多研究小组中，体重、体重指数 (BMI) 和腰围被发现与前列腺体积呈正相关。此外，流行病学数据显示，肥胖可能会增加对 BPH 手术和 BPH 治疗的需求。
根据《美国男性健康杂志》(AJMH) 的数据，2019 年，全球有2019 年，BPH 引起的新发病例为 1126 万例，YLD 为 186 万例。1990 年至 2019 年期间，全球 BPH 发病率增加了 105.7%，YLD 增加了 110.6%。在此期间，全球范围内的绝对发病率和 YLD 数量大幅增加，这主要是由于人口增加和老龄化。 BPH 的治疗选择包括经尿道前列腺切除术 (TURP)、开放性前列腺切除术等手术，以及经尿道针刺消融术 (TUNA) 等微创治疗。良性前列腺增生装置用于微创治疗，如射频消融、激光治疗和植入。因此，良性前列腺增生症患病率的增加和相关风险因素增加了对良性前列腺增生装置的需求。
北美良性前列腺增生装置市场收入到 2028 年的预测（百万美元）
北美良性前列腺增生设备市场细分
北美良性前列腺增生设备市场根据产品、手术类型、最终用户进行细分和国家。根据产品，市场分为电切镜、泌尿外科激光器、射频消融设备、前列腺支架和植入物。电切镜细分市场预计将在 2022 年占据最大的市场份额。另一方面，泌尿外科激光细分市场预计在预测期内复合年增长率最高。根据手术类型，北美良性前列腺增生器械市场分为经尿道微波治疗、经尿道前列腺切除术、经尿道前列腺针消融术、激光手术、尿路提升手术等。经尿道前列腺切除术在 2022 年占据最大的市场份额，预计在预测期内也将实现最高的市场复合年增长率。根据最终用户，北美良性前列腺增生设备市场分为医院、诊所、门诊手术中心等。医院细分市场在 2022 年占据最大的市场份额，而诊所细分市场预计在预测期内复合年增长率最高。按国家/地区划分，北美良性前列腺增生设备市场分为美国、加拿大和墨西哥。 2022 年，美国占据最大的市场份额，预计在预测期内复合年增长率最高。
KARL STORZ SE &两合公司；奥林巴斯公司；波士顿科学公司；泰利福公司；理查德·沃尔夫有限公司； Urologix 有限责任公司； OmniGuide 控股公司；和 Convergent Laser Technologies 是北美良性前列腺增生设备市场的领先公司之一。
Strategic insights for North America Benign Prostatic Hyperplasic Devices involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 863.12 Million |
| Market Size by 2028 | US$ 1,349.19 Million |
| Global CAGR (2022 - 2028) | 7.7% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By 产品
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Benign Prostatic Hyperplasic Devices refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Benign Prostatic Hyperplasic Devices Market is valued at US$ 863.12 Million in 2022, it is projected to reach US$ 1,349.19 Million by 2028.
As per our report North America Benign Prostatic Hyperplasic Devices Market, the market size is valued at US$ 863.12 Million in 2022, projecting it to reach US$ 1,349.19 Million by 2028. This translates to a CAGR of approximately 7.7% during the forecast period.
The North America Benign Prostatic Hyperplasic Devices Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Benign Prostatic Hyperplasic Devices Market report:
The North America Benign Prostatic Hyperplasic Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Benign Prostatic Hyperplasic Devices Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Benign Prostatic Hyperplasic Devices Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Benign Prostatic Hyperplasic Devices Market
